Desheng Xiao

6.3k total citations · 6 hit papers
116 papers, 4.4k citations indexed

About

Desheng Xiao is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Desheng Xiao has authored 116 papers receiving a total of 4.4k indexed citations (citations by other indexed papers that have themselves been cited), including 70 papers in Molecular Biology, 35 papers in Cancer Research and 31 papers in Oncology. Recurrent topics in Desheng Xiao's work include RNA modifications and cancer (32 papers), Epigenetics and DNA Methylation (22 papers) and Ferroptosis and cancer prognosis (20 papers). Desheng Xiao is often cited by papers focused on RNA modifications and cancer (32 papers), Epigenetics and DNA Methylation (22 papers) and Ferroptosis and cancer prognosis (20 papers). Desheng Xiao collaborates with scholars based in China, Saudi Arabia and United States. Desheng Xiao's co-authors include Yongguang Tao, Chao Mao, Yating Liu, Ya Cao, Weiwei Lai, Shuang Liu, Ying Shi, Lianlian Ouyang, Hu Zhou and Na Liu and has published in prestigious journals such as Proceedings of the National Academy of Sciences, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

Desheng Xiao

111 papers receiving 4.4k citations

Hit Papers

5 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Long noncoding RNA LINC00336 inhibits ferroptosis in lung cancer by functioning as a competing endogenous RNA

2019 429 citations Min Wang, Chao Mao et al. Cell Death and Differentiation profile →
A G3BP1-Interacting lncRNA Promotes Ferroptosis and Apoptosis in Cancer via Nuclear Sequestration of p53

2018 402 citations Chao Mao, Xiang Wang et al. Cancer Research profile →
The epigenetic regulators and metabolic changes in ferroptosis-associated cancer progression

2020 263 citations Desheng Xiao, Shuang Liu et al. Molecular Cancer profile →
Emerging mechanisms and targeted therapy of ferroptosis in cancer

2021 236 citations Haiyan Wang, Chao Mao et al. profile →
Farnesoid X receptor (FXR): Structures and ligands

2021 163 citations Longying Jiang, Desheng Xiao et al. profile →
Signaling pathways in cancer metabolism: mechanisms and therapeutic targets

2023 146 citations Desheng Xiao, Shuang Liu et al. Signal Transduction and Targeted Therapy profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Desheng Xiao China	29	3.2k	2.3k	1.8k	651	268	116	4.4k
Shiqi Wu United States	23	2.0k 0.6×	1.3k 0.6×	1.7k 1.0×	509 0.8×	236 0.9×	62	3.2k
Yilong Zou United States	20	2.4k 0.8×	1.4k 0.6×	1.6k 0.9×	1.2k 1.9×	432 1.6×	30	4.1k
Yin Sun China	35	3.1k 1.0×	1.6k 0.7×	724 0.4×	758 1.2×	296 1.1×	116	4.2k
Hyemin Lee United States	18	3.8k 1.2×	3.2k 1.4×	3.0k 1.7×	443 0.7×	286 1.1×	25	5.2k
Chao Mao China	27	4.2k 1.3×	3.3k 1.5×	3.7k 2.1×	609 0.9×	356 1.3×	78	6.2k
Qiuhui Pan China	31	4.3k 1.4×	3.1k 1.3×	1.5k 0.8×	898 1.4×	343 1.3×	66	5.7k
Meizuo Zhong China	24	1.7k 0.6×	1.2k 0.5×	1.1k 0.6×	706 1.1×	251 0.9×	74	2.9k
Jun Huang China	30	2.1k 0.7×	1.3k 0.6×	982 0.6×	491 0.8×	373 1.4×	81	3.3k
Paolo Ceppi Italy	30	1.9k 0.6×	1.2k 0.5×	1.0k 0.6×	1.3k 2.0×	330 1.2×	54	3.3k

Countries citing papers authored by Desheng Xiao

Since Specialization

Citations

This map shows the geographic impact of Desheng Xiao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Desheng Xiao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Desheng Xiao more than expected).

Fields of papers citing papers by Desheng Xiao

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Desheng Xiao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Desheng Xiao. The network helps show where Desheng Xiao may publish in the future.

Co-authorship network of co-authors of Desheng Xiao

This figure shows the co-authorship network connecting the top 25 collaborators of Desheng Xiao. A scholar is included among the top collaborators of Desheng Xiao based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Desheng Xiao. Desheng Xiao is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Cao, Jing, Kui Chen, Kuan Hu, et al.. (2025). USP2-mediated PPARγ stabilization promotes hepatocellular carcinoma progression and M2 macrophage polarization via oleic acid. Journal for ImmunoTherapy of Cancer. 13(11). e012721–e012721.

Tao, Yongguang, et al.. (2025). Mechanism of Ferroptosis and Its Role in Disease Development. International Journal of Biological Sciences. 21(12). 5328–5360. 2 indexed citations

Chen, Ling, Jun Tang, Na Liu, et al.. (2024). USP13 facilitates a ferroptosis-to-autophagy switch by activation of the NFE2L2/NRF2-SQSTM1/p62-KEAP1 axis dependent on the KRAS signaling pathway. Autophagy. 21(3). 565–582. 10 indexed citations

Jiang, Longying, Xujun Liang, Shuyan Dai, et al.. (2024). Structural characterization of the DNA binding mechanism of retinoic acid-related orphan receptor gamma. Structure. 32(4). 467–475.e3. 2 indexed citations

Tang, Jun, Xiang Wang, Desheng Xiao, Shuang Liu, & Yongguang Tao. (2023). The chromatin-associated RNAs in gene regulation and cancer. Molecular Cancer. 22(1). 27–27. 28 indexed citations

Xie, Bin, et al.. (2023). Mutations and expressions of breast cancer 1/2 in lung cancer. Thoracic Cancer. 14(18). 1753–1763. 5 indexed citations

Tang, Jianing, Guo Long, Desheng Xiao, et al.. (2023). ATR‐dependent ubiquitin‐specific protease 20 phosphorylation confers oxaliplatin and ferroptosis resistance. SHILAP Revista de lepidopterología. 4(6). e463–e463. 16 indexed citations

Yan, Qijia, et al.. (2023). Microsatellite Status Detection of Colorectal Cancer: Evaluation of Inconsistency between PCR and IHC. Journal of Cancer. 14(7). 1132–1140. 9 indexed citations

Long, Yao, Jiaxing Guo, Jielin Chen, et al.. (2023). GPR162 activates STING dependent DNA damage pathway as a novel tumor suppressor and radiation sensitizer. Signal Transduction and Targeted Therapy. 8(1). 48–48. 29 indexed citations

10.

Tang, Jianing, Guo Long, Kuan Hu, et al.. (2023). Targeting USP8 Inhibits O‐GlcNAcylation of SLC7A11 to Promote Ferroptosis of Hepatocellular Carcinoma via Stabilization of OGT. Advanced Science. 10(33). e2302953–e2302953. 65 indexed citations

11.

Wang, Zuli, Lianlian Ouyang, Tiansheng Li, et al.. (2023). The DUBA-SLC7A11-c-Myc axis is critical for stemness and ferroptosis. Oncogene. 42(36). 2688–2700. 22 indexed citations

12.

Tang, Jianing, Qian Yang, Chao Mao, et al.. (2023). The deubiquitinating enzyme UCHL3 promotes anaplastic thyroid cancer progression and metastasis through Hippo signaling pathway. Cell Death and Differentiation. 30(5). 1247–1259. 36 indexed citations

13.

Ouyang, Lianlian, Yangying Zhou, Weiwei Lai, et al.. (2023). AhR Promotes the Development of Non-small cell lung cancer by Inducing SLC7A11-dependent Antioxidant Function. Journal of Cancer. 14(5). 821–834. 24 indexed citations

14.

Liu, Shouping, Weiwei Lai, Ying Shi, et al.. (2020). Annotation and cluster analysis of long noncoding RNA linked to male sex and estrogen in cancers. npj Precision Oncology. 4(1). 5–5. 13 indexed citations

15.

Liu, Yating, Chao Mao, Min Wang, et al.. (2020). Cancer progression is mediated by proline catabolism in non-small cell lung cancer. Oncogene. 39(11). 2358–2376. 60 indexed citations

16.

Wang, Min, Chao Mao, Lianlian Ouyang, et al.. (2019). Long noncoding RNA LINC00336 inhibits ferroptosis in lung cancer by functioning as a competing endogenous RNA. Cell Death and Differentiation. 26(11). 2329–2343. 429 indexed citations breakdown →

17.

Wang, Min, Chao Mao, Lianlian Ouyang, et al.. (2019). Correction to: Long noncoding RNA LINC00336 inhibits ferroptosis in lung cancer by functioning as a competing endogenous RNA. Cell Death and Differentiation. 27(4). 1447–1447. 26 indexed citations

18.

Mao, Chao, Xiang Wang, Yating Liu, et al.. (2018). A G3BP1-Interacting lncRNA Promotes Ferroptosis and Apoptosis in Cancer via Nuclear Sequestration of p53. Cancer Research. 78(13). 3484–3496. 402 indexed citations breakdown →

19.

Fan, Weibing, Juan Feng, Desheng Xiao, et al.. (2017). Elevated expression of HSP10 protein inhibits apoptosis and associates with poor prognosis of astrocytoma. PLoS ONE. 12(10). e0185563–e0185563. 22 indexed citations

20.

Deng, Zhenghao, Jifang Wen, Jinghe Li, Desheng Xiao, & Jianhua Zhou. (2008). Activator protein-1 involved in growth inhibition by RASSF1A gene in the human gastric carcinoma cell line SGC7901. World Journal of Gastroenterology. 14(9). 1437–1437. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact